Diagnostic and pathogenic significance of glutamate receptor autoantibodies

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.

Original languageEnglish (US)
Pages (from-to)589-592
Number of pages4
JournalArchives of Neurology
Volume65
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Glutamate Receptors
Autoantibodies
Brain Diseases
Encephalitis
Systemic Lupus Erythematosus
Olivopontocerebellar Atrophies
Partial Epilepsy
Transient Ischemic Attack
Neurologic Manifestations
Brain Ischemia
Central Nervous System
Biomarkers
Epilepsy
Evaluation
Attack
Diagnostics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Diagnostic and pathogenic significance of glutamate receptor autoantibodies. / Pleasure, David E.

In: Archives of Neurology, Vol. 65, No. 5, 05.2008, p. 589-592.

Research output: Contribution to journalArticle

@article{38d956e83b754355bef5a64270c7195a,
title = "Diagnostic and pathogenic significance of glutamate receptor autoantibodies",
abstract = "Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.",
author = "Pleasure, {David E}",
year = "2008",
month = "5",
doi = "10.1001/archneur.65.5.589",
language = "English (US)",
volume = "65",
pages = "589--592",
journal = "Archives of Neurology",
issn = "0003-9942",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Diagnostic and pathogenic significance of glutamate receptor autoantibodies

AU - Pleasure, David E

PY - 2008/5

Y1 - 2008/5

N2 - Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.

AB - Autoantibodies against glutamate receptors, first reported in Rasmussen encephalitis, have been observed in other focal epilepsies, central nervous system ischemic infarcts, transient ischemic attacks, sporadic olivopontocerebellar atrophy, systemic lupus erythematosus, and paraneoplastic encephalopathies. The detection of glutamate receptor autoantibodies is not useful in the evaluation of Rasmussen encephalitis but may be a biomarker for brain ischemia, and it is helpful in diagnosing certain paraneoplastic encephalopathies. Passive transfer of glutamate receptor autoantibodies from patients with systemic lupus erythematosus or paraneoplastic encephalopathy suggests that glutamate receptor autoantibodies can actively contribute to neurologic dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=43549126023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549126023&partnerID=8YFLogxK

U2 - 10.1001/archneur.65.5.589

DO - 10.1001/archneur.65.5.589

M3 - Article

C2 - 18474732

AN - SCOPUS:43549126023

VL - 65

SP - 589

EP - 592

JO - Archives of Neurology

JF - Archives of Neurology

SN - 0003-9942

IS - 5

ER -